Precision Cellular Therapies for Longevity & Repair

Stem cell therapy is being actively studied for its potential role in tissue regeneration, neurological function, immune modulation, and overall cellular health. At Decima, we take a comprehensive approach, offering regenerative strategies for a wide range of health concerns, including:

• Autoimmune conditions and immune system support

• Neurological wellness and neuroregenerative applications

• Musculoskeletal health, including pain management and tissue repair

• Longevity and cellular optimization, focusing on overall resilience and performance

Our team, led by specialists in pain management and musculoskeletal health, ensures that each treatment plan is tailored to the patient’s individual needs. However, we do not offer treatments for conditions where no viable tissue remains, such as completely bald areas or joints with total cartilage loss (bone-on-bone cases).

The cost varies based on the type of treatment and the area being addressed. At Decima, we provide competitive pricing by maintaining efficient, decentralized operations, allowing us to offer high quality cellular therapies at a more accessible price point. Pricing starts at $2,500, with package options available for those interested in multiple sessions or specialized treatments.

Our process begins with an initial consultation to assess your specific needs and determine the most appropriate approach. Once a treatment plan is established, we handle all necessary pre-treatment diagnostics, including bloodwork and biomarker analysis.

Treatments are minimally invasive, outpatient procedures, allowing most patients to resume normal activities shortly after their session. Our team provides ongoing support and follow-ups to ensure an optimal experience and address any post-treatment questions.

Stem cell therapies have been extensively studied, and when conducted by experienced professionals using high quality, rigorously screened cells, they are considered safe within the scope of regenerative medicine. At Decima, we prioritize patient safety and scientific integrity by exclusively using mesenchymal stem cells (MSCs) from Wharton’s jelly, which have been studied for decades and are associated with a strong safety profile in research settings.

Our cells undergo multi step quality verification and independent third-party testing to ensure purity, viability, and consistency. We do not use fat or bone marrow derived stem cells due to potential safety concerns and inconsistent efficacy. Our focus remains on delivering biologically potent, research backed therapies with the highest safety standards.